Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Articles

Page 3 of 74

  1. To investigate the early predictive value of dynamic magnetic resonance imaging (MRI)-based radiomics for progression and prognosis in locally advanced cervical cancer (LACC) patients treated with concurrent c...

    Authors: Chang Cai, Ji-Feng Xiao, Rong Cai, Dan Ou, Yi-Wei Wang, Jia-Yi Chen and Hao-Ping Xu
    Citation: Radiation Oncology 2024 19:181
  2. Laryngeal cancer is a common head and neck cancer. Surgical treatment can impair patients’ voice and swallowing function, making definitive radiotherapy a viable alternative for locally advanced cases.

    Authors: Ali Kazemian, Ebrahim Esmati, Reza Ghalehtaki, Borna Farazmand, Nima Mousavi-Darzikolaee, Reyhaneh Bayani, Mahdieh Razmkhah, Maryam Taherioun, Niloufar Saeedi, Farrokh Heidari and Kaveh Zakeri
    Citation: Radiation Oncology 2024 19:180
  3. Rectal cancer patients are potential beneficiaries of adaptive radiotherapy (ART) which demands considerable resources. Currently, there is no definite guidance on what kind of patients and when will benefit f...

    Authors: Liyuan Chen, Lei Yu, Huanli Luo, Yanju Yang, Zhen Zhang, Fu Jin, Weigang Hu and Jiazhou Wang
    Citation: Radiation Oncology 2024 19:179
  4. This study evaluates the dosimetric impact of tumor matching (TM) and bone matching (BM) in carbon ion radiotherapy for locally advanced non-small cell lung cancer.

    Authors: Jing Mi, Shubin Jia, Liyuan Chen, Yaqi Li, Jiayao Sun, Liwen Zhang, Jingfang Mao, Jian Chen, Ningyi Ma, Jingfang Zhao and Kailiang Wu
    Citation: Radiation Oncology 2024 19:178
  5. This study aims to investigate the prognostic impact of ground-glass opacity (GGO)-component in early-stage lung cancer patients treated with stereotactic body radiotherapy (SBRT).

    Authors: Jintao Ma, Shaonan Fan, Wenhan Huang, Xiaohong Xu, Yong Hu and Jian He
    Citation: Radiation Oncology 2024 19:177
  6. The purpose of this study was to quantify the intra- and interfraction motion of the target volume and organs at risk (OARs) during adaptive radiotherapy (ART) for uterine cervical cancer (UCC) using MR-Linac ...

    Authors: Huadong Wang, Zhenkai Li, Dengxin Shi, Peijun Yin, Benzhe Liang, Jingmin Zou, Qiuqing Tao, Wencheng Ma, Yong Yin and Zhenjiang Li
    Citation: Radiation Oncology 2024 19:176
  7. While there is a growing amount of data on the cardiac toxicity of radiotherapy (RT) in relation to its impact on cardiac sub-structures (CSS), there are only few studies addressing this issue in patients foll...

    Authors: Victor Nguyen, Jean-Philippe Metges, Moncef Morjani, Pierre-Guillaume Pourreau, Estelle Dhamelincourt, Lucille Quenehervé, Olivier Pradier and Vincent Bourbonne
    Citation: Radiation Oncology 2024 19:175
  8. Local recurrence of rectal cancer (LRRC) previously treated with radiotherapy is associated with a poor prognosis. Historically, the integration of radiotherapy (RT) with surgery has improved the likelihood of...

    Authors: Maria Antonietta Gambacorta, Angela Romano, Luciana Caravatta, Gabriella Macchia, Giuditta Chiloiro, Elena Galofaro, Francesca Valvo, Viviana Vitolo, Daniela Alterio and Giovanna Mantello
    Citation: Radiation Oncology 2024 19:174
  9. The use of stereotactic body radiotherapy (SBRT) to definitively treat oligometastases in prostate cancer has drawn large clinical and research interests within radiation oncology. However, the evidence is con...

    Authors: Astrid E. Persson, Andreas Hallqvist, Louise Bjørn Larsen, Mette Rasmussen, Jonas Scherman, Per Nilsson, Hanne Tønnesen and Adalsteinn Gunnlaugsson
    Citation: Radiation Oncology 2024 19:173
  10. Current approaches for locally advanced rectal cancer (LARC) typically recommend neoadjuvant chemoradiotherapy (nCRT) with 5-fluorouracil (5FU) or its oral analogs followed by surgery as the standard of care. ...

    Authors: Amirali Azimi, Fatemeh Sadat Tabatabaei, Kasra Kolahdouzan, Hamideh Rashidian, Forouzan Nourbakhsh, Maryam Abedini Parizi, Nima Mousavi Darzikolaee, Reyhaneh Bayani, Samaneh Salarvand, Azadeh Sharifian, Farzaneh Bagheri, Saeed Rezaei, Naeim Nabian, Reza Nazari, Negin Mohammadi, Mohammad Babaei…
    Citation: Radiation Oncology 2024 19:172
  11. Antipsychotic drugs (APDs) are used for treating mental illnesses and are also used by cancer patients. This study aimed to evaluate APD use in adult cancer patients who received radiotherapy (RT) in South Kor...

    Authors: In Gyu Hwang, Song E Park, Sun Mi Kim, Dae Ryong Kang, Tae-Hwa Go, Se Hwa Hong, Yong-Chan Ha, Shin Young Park, Hyunho Lee and Jin Hwa Choi
    Citation: Radiation Oncology 2024 19:171
  12. Accurate calculation of lung cancer dose using the Monte Carlo (MC) algorithm in CyberKnife (CK) is essential for precise planning. We aim to employ deep learning to directly predict the 3D dose distribution c...

    Authors: Yuchao Miao, Jiwei Li, Ruigang Ge, Chuanbin Xie, Yaoying Liu, Gaolong Zhang, Mingchang Miao and Shouping Xu
    Citation: Radiation Oncology 2024 19:170
  13. Post-Therapy-Pneumonitis (PTP) is a critical side effect of both, thoracic radio(chemo)therapy (R(C)T) and immune checkpoint inhibition (ICI). However, disease characteristics and patient-specific risk factors...

    Authors: Kim Melanie Kraus, Caroline Bauer, Lisa Steinhelfer, Benedikt Feuerecker, Juliana Cristina Martins, Julius Clemens Fischer, Kai Joachim Borm, Jan Caspar Peeken, Denise Bernhardt and Stephanie Elisabeth Combs
    Citation: Radiation Oncology 2024 19:169
  14. The delineation of organs-at-risk and lymph node areas is a crucial step in radiotherapy, but it is time-consuming and associated with substantial user-dependent variability in contouring. Artificial intellige...

    Authors: Céline Meyer, Sandrine Huger, Marie Bruand, Thomas Leroy, Jérémy Palisson, Paul Rétif, Thomas Sarrade, Anais Barateau, Sophie Renard, Maria Jolnerovski, Nicolas Demogeot, Johann Marcel, Nicolas Martz, Anaïs Stefani, Selima Sellami, Juliette Jacques…
    Citation: Radiation Oncology 2024 19:168

    The Correction to this article has been published in Radiation Oncology 2025 20:13

  15. Metastatic prostate cancer remains a therapeutic challenge. Based on data of the STAMPEDE trial, patients with a low metastatic burden showed prolonged failure-free and overall survival when treated with prost...

    Authors: Kristina K. M. Kramer, Nina-Sophie Schmidt-Hegemann, Thilo Westhofen, Marco Foglar, Jens Ricke, C. Benedikt Westphalen, Marcus Unterrainer, Wolfgang G. Kunz and Dirk Mehrens
    Citation: Radiation Oncology 2024 19:167
  16. During the day-night cycle, gravity and applied stress to the body mass and spine causes a decrease in body height, which is restored overnight. This diurnal spine length variation has not yet been quantified ...

    Authors: Karin M. Meijer, Irma W.E.M. van Dijk, Tamara J. Schonk, Brian V. Balgobind, Anna Loginova, Niek van Wieringen and Arjan Bel
    Citation: Radiation Oncology 2024 19:166
  17. The potential of carbon ion radiation therapy (CIRT) as a curative treatment for localized prostate cancer (PCa) has garnered attention due to its characteristic dose distribution. We prospectively collected a...

    Authors: Yoshiyuki Miyazawa, Hiroshi Nakayama, Hidemasa Kawamura, Yuhei Miyasaka, Masahiro Onishi, Takuya Kaminuma, Yoshitaka Sekine, Hiroshi Matsui, Tatsuya Ohno and Kazuhiro Suzuki
    Citation: Radiation Oncology 2024 19:165
  18. The present study aimed to evaluate the use of 18F-2-[18F]-fluoro-2-deoxy-d-glucose (FDG) PET/MRI (Positron emission tomography-computed tomography) in predicting the pathological response to neoadjuvant chemothe...

    Authors: Milad Ghanikolahloo, Hayder Jasim Taher, Ayoob Dinar Abdullah, Mahsa Asadi Anar, Ali Tayebi, Rahil Rahimi, Faranak Olamaeian, Nima Rahimikashkooli and Nima Kargar
    Citation: Radiation Oncology 2024 19:164
  19. The purpose of this study is to assess the feasibility of mixed-reality (MixR) visualization for patient setup in breast and chest wall radiotherapy (RT) by performing a first-in-human clinical trial comparing...

    Authors: Perry B. Johnson, Julie Bradley, Samsun Lampotang, Amanda Jackson, David Lizdas, William Johnson, Eric Brooks, Raymond B. Mailhot Vega and Nancy Mendenhall
    Citation: Radiation Oncology 2024 19:163
  20. To evaluate the impact of prophylactic cranial irradiation (PCI) on the prognosis of patients with limited-stage small cell lung cancer (SCLC) in the era of MRI surveillance.

    Authors: Mengyuan Chen, Zehua Sun, Jingcong Pan, Yujin Xu, Yuezhen Wang, Ming Chen and Xiao Hu
    Citation: Radiation Oncology 2024 19:162
  21. Craniopharyngioma is a rare and slow-growing benign sellar or parasellar epithelial tumor. The number of patients receiving proton beam therapy (PBT) has increased. This study aimed to systematically evaluate ...

    Authors: Zhi Li, Qingyong Li, Haidong Tian, Maoqing Wang, Ru Lin, Juan Bai, Dandan Wang and Meng Dong
    Citation: Radiation Oncology 2024 19:161
  22. Intrahepatic cholangiocarcinoma (ICC) is a challenging primary liver cancer with a poor prognosis, especially in unresectable cases. Traditional palliative irradiation is limited in reducing liver doses. This ...

    Authors: Akihito Okubo, Sae Matsumoto, Hiroyasu Tamamura, Yoshitaka Sato, Satoko Asahi, Hitoshi Tatebe, Kazutaka Yamamoto, Keiichiro Matsushita, Makoto Sasaki, Yoshikazu Maeda, Yuji Tameshige, Hajime Sunagozaka, Hiroyuki Aoyagi, Satoshi Shibata, Shigeyuki Takamatsu and Satoshi Kobayashi
    Citation: Radiation Oncology 2024 19:160
  23. Pulsed low dose rate radiotherapy (PLDR) is a new radiation delivery method, in which the fractional dose is divided into sub-fractional doses with periodical time breaks in between. The goal of our study is t...

    Authors: Noha Roshdy Salem, Ahmed Eldib, E. M. El-Sayed, Ehab Mostafa and Omar S. Desouky
    Citation: Radiation Oncology 2024 19:159
  24. The aim of this study was to evaluate the inter-fraction reproducibility and intra-fraction stability of breast radiotherapy using voluntary deep-inspiration breath hold (DIBH) and free breathing (FB) based on...

    Authors: Junxiang Wu, Feng Yang, Jie Li, Xianliang Wang, Ke Yuan, Lipeng Xu, Fan Wu, Bin Tang and Lucia Clara Orlandini
    Citation: Radiation Oncology 2024 19:158
  25. Recent research has demonstrated that the use of artificial intelligence (AI) in radiotherapy (RT) has significantly streamlined the process for physicians to treat patients with tumors; however, bibliometric ...

    Authors: Minghe Lv, Yue feng, Su Zeng, Yang Zhang, Wenhao Shen, Wenhui Guan, Xiangyu E., Hongwei Zeng, Ruping Zhao and Jingping Yu
    Citation: Radiation Oncology 2024 19:157
  26. Durvalumab, an anti-PD-L1 immune checkpoint inhibitor, after radio-chemotherapy (RCT) has changed the management of locally advanced non-small cell lung cancer (LA NSCLC). A series of retrospective studies hav...

    Authors: Arnaud Colomb, Benoit Allignet, Mehdi Lamkhioued, Aurelie Swalduz, Lionel Falchero, Aurélie Kienlen, Michaël Duruisseaux and Coralie Moncharmont
    Citation: Radiation Oncology 2024 19:156
  27. Growth differentiation factor 15 (GDF15) is a cytokine of the TGFβ family. Here, we analyzed GDF15 levels in patients with locally advanced non-small cell lung cancer (LA-NSCLC) who participated in OCOG-ALMERA...

    Authors: Fiorella Di Pastena, Gregory Pond, Evangelia E. Tsakiridis, Andre Gouveia, Elham Ahmadi, Olga-Demetra Biziotis, Amr Ali, Anand Swaminath, Gordon Okawara, Peter M. Ellis, Bassam Abdulkarim, Naseer Ahmed, Andrew Robinson, Wilson Roa, Mario Valdes, Peter Kavsak…
    Citation: Radiation Oncology 2024 19:155
  28. Tyrosine Kinase Inhibitors (TKIs) is an important therapy for patients with oncogene-mutated Non-Small Cell Lung Cancer (NSCLC). However, acquired resistance remains a major challenge. The efficacy of TKIs plu...

    Authors: Wenxia Li, Peiye Wu, Zhanpeng Liang, Luzhen Li, Yunqi Chen, Wenjing Zhang, Huatang Zhang and Cantu Fang
    Citation: Radiation Oncology 2024 19:154
  29. In locally advanced rectal cancer, the prediction of tumor response during and after neoadjuvant treatment remains challenging. In terms of organ preservation, adaptive radiotherapy, and intensified (total) ne...

    Authors: Kerstin Clasen, Cihan Gani, Leon Schuetz, Stephan Clasen, Nadja Ballin, Irina Bonzheim, Michael Orth, Stephan Ossowski, Olaf Riess, Maximilian Niyazi, Christopher Schroeder and Olga Kelemen
    Citation: Radiation Oncology 2024 19:153
  30. This study aims to evaluate the efficacy and safety of 3D printing technology in brachytherapy for cervical cancer, comparing its outcomes with conventional free hand implantation brachytherapy.

    Authors: Zenghong Lu, Gangfeng Zhu, Zhengang Qiu, Hailiang Guo, Junyan Li, Liangjian Zheng, Cixiang Chen, Jie Che, Yi Xiang and Yili Wang
    Citation: Radiation Oncology 2024 19:152
  31. Complex high-precision radiotherapy, such as stereotactic body radiotherapy (SBRT), should only be offered to patients with sufficiently long survival. In the context of bone metastases radiotherapy, low rates...

    Authors: Carsten Nieder, Ellinor C. Haukland, Luka Stanisavljevic and Bård Mannsåker
    Citation: Radiation Oncology 2024 19:151
  32. Head and neck squamous cell carcinoma (HNSCC) negative for Human Papillomavirus (HPV) has remained a difficult to treat entity, whereas tumors positive for HPV are characterized by radiosensitivity and favorab...

    Authors: Henrike Barbara Zech, Clara von Bargen, Agnes Oetting, Nikolaus Möckelmann, Christina Möller-Koop, Melanie Witt, Nina Struve, Cordula Petersen, Christian Betz, Kai Rothkamm, Adrian Münscher, Till Sebastian Clauditz and Thorsten Rieckmann
    Citation: Radiation Oncology 2024 19:150
  33. Magnetic resonance imaging is indispensable for the preoperative diagnosis of glioma. This study aimed to investigate the role of the apparent diffusion coefficient values as predictors of survival in patients...

    Authors: Xue Jiang, Xu-Ni Xu, Xiao-Ye Yuan, Hao-Ran Jiang, Meng-Jing Zhao, Yu-Xia Duan and Gang Li
    Citation: Radiation Oncology 2024 19:149
  34. Increasing evidence suggests that a subgroup of patients with oligometastatic cancer might achieve a prolonged disease-free survival through local therapy for all active cancer lesions. Our aims are to investi...

    Authors: Sebastian M. Christ, Gabriel W. Thiel, Philip Heesen, Siyer Roohani, Michael Mayinger, Jonas Willmann, Maiwand Ahmadsei, Urs J. Muehlematter, Alexander Maurer, Josef A. Buchner, Jan C. Peeken, Rifaquat Rahman, Ayal Aizer, Emilie Le Rhun, Nicolaus Andratschke, Michael Weller…
    Citation: Radiation Oncology 2024 19:148
  35. Recurrent and locally advanced gynecological malignancies have a poor prognosis. In particularly, pelvic local recurrence after previous radiotherapy and/or positive resection margins during surgical treatment...

    Authors: Tanja Sprave, Raluca Stoian, Natalia Volegova-Neher, Mark Gainey, Michael Kollefrath, Dimos Baltas, Anca-Ligia Grosu, Ingolf Juhasz-Böss, Rieke Schröder and Florin-Andrei Taran
    Citation: Radiation Oncology 2024 19:147
  36. This study aims to assess the clinical efficacy of elective neck irradiation (ENI) in patients with esthesineuroblastoma (ENB), a rare malignant neoplasm, who are clinically node-negative.

    Authors: Yang Zhao, Li Yan, Ruichen Li, Xiaoshen Wang and Yi Zhu
    Citation: Radiation Oncology 2024 19:146
  37. Using dose-painted intensity-modulated radiation therapy, specific dose volume constraints or implantation of tissue expanders prior to radiotherapy are validated options for reducing radiation dose on the bow...

    Authors: L. Hoeng, A. K. Exeli, G. A. Krombach, T. Schwandner, L. Agolli and D. Habermehl
    Citation: Radiation Oncology 2024 19:145
  38. To investigate the impact of using contrast-enhanced computed tomography (CHCT) in the dosimetry of stereotactic body radiation therapy (SBRT) for liver metastases treated with MR-Linac.

    Authors: Min Liu, Mingzhe Liu, Feng Yang, Yanhua Liu, Shoulong Wang, Yazhen Chen, Jie Li, Xianliang Wang and Lucia Clara Orlandini
    Citation: Radiation Oncology 2024 19:144
  39. The purpose of this study was to investigate the survival benefit of Stereotactic Body Radiotherapy (SBRT) versus lenvatinib as first-line therapy in the treatment of hepatocellular carcinoma (HCC) with portal...

    Authors: Xiaoquan ji, Aimin Zhang, Xuezhang Duan and Quan Wang
    Citation: Radiation Oncology 2024 19:143
  40. Merkel cell carcinoma (MCC) radiation treatment has historically consisted of standard 1.8–2 Gy fractions treated daily over 4–6 weeks. Hypofractionated treatment regimens have demonstrated tumor control and t...

    Authors: Lorein Gonzalez, Muni Rubens, Sreenija Yarlagadda, Guilherme Rabinowits and Noah S. Kalman
    Citation: Radiation Oncology 2024 19:142
  41. The advancement of precision radiotherapy techniques, such as volumetric modulated arc therapy (VMAT), stereotactic body radiotherapy (SBRT), and particle therapy, highlights the importance of radiotherapy in ...

    Authors: Xiangbin Zhang, Di Yan, Haonan Xiao and Renming Zhong
    Citation: Radiation Oncology 2024 19:140
  42. This observational study aims to establish the feasibility of using x-ray images of radio-opaque chemoembolisation deposits in patients as a method for real-time image-guided radiation therapy of hepatocellula...

    Authors: Natalie Plant, Adam Mylonas, Chandrima Sengupta, Doan Trang Nguyen, Shona Silvester, David Pryor, Peter Greer, Yoo Young (Dominique) Lee, Prabhakar Ramachandran, Venkatakrishnan Seshadri, Yuvnik Trada, Richard Khor, Tim Wang, Nicholas Hardcastle and Paul Keall
    Citation: Radiation Oncology 2024 19:139
  43. The aim was to study the potential for an online fully automated daily adaptive radiotherapy (RT) workflow for bladder cancer, employing a focal boost and fiducial markers. The study focused on comparing the g...

    Authors: Sana Azzarouali, Karin Goudschaal, Jorrit Visser, Laurien Daniëls, Arjan Bel and Duncan den Boer
    Citation: Radiation Oncology 2024 19:138
  44. Definitive concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced, inoperable non-small cell lung cancer (NSCLC). Previous studies have mainly focused on examining local failure and...

    Authors: Feifan Sun, Zhiming Chen, Daijun Zhou, Zhihui Li, Haoyang Wang, Rong Zhao, Jing Xian, Jingjing Peng, Xingchen Peng, Chaoyang Jiang, Mei Shi and Dong Li
    Citation: Radiation Oncology 2024 19:137
  45. This report details the experience of a patient who developed a second primary glioblastoma (GB), offering insights into the treatment process and reviewing relevant literature.

    Authors: Bai Jiwei, Muyasha Abulimiti, Jin Yonglong, Wang Jie, Zhang Shuyan, Liu Chao, Wang Zishen, Wang Wei, Li Yinuo, Wang Weiwei, Yang Lu and Shosei Shimizu
    Citation: Radiation Oncology 2024 19:136
  46. Anaplastic meningiomas, categorized as WHO grade 3 tumors, are rare and highly aggressive, accounting for 1-2% of all meningioma cases. Despite aggressive treatment, including surgery and Radiation, they exhib...

    Authors: Ory Haisraely, Alicia Taliansky, Maayan Sivan and Yaacov Lawerence
    Citation: Radiation Oncology 2024 19:135
  47. We conducted a systematic review and meta-analysis to assess the risk of respiratory adverse effects in patients with solid tumors treated with immune checkpoint inhibitors (PD-1, PD-L1 and CTLA-4 inhibitors) ...

    Authors: Zhongjun Ma, Jiexuan Hu, Fei Wu, Naijia Liu and Qiang Su
    Citation: Radiation Oncology 2024 19:134
  48. The 3-variable number-of-risk-factors (NRF) model is a prognostic tool for patients undergoing palliative radiotherapy (PRT). However, there is little research on the NRF model for patients with painful non-bo...

    Authors: Takayuki Sakurai, Tetsuo Saito, Kohsei Yamaguchi, Shigeyuki Takamatsu, Satoshi Kobayashi, Naoki Nakamura and Natsuo Oya
    Citation: Radiation Oncology 2024 19:133
  49. This study aimed to use propensity score matching (PSM) to explore the long-term outcomes and failure patterns in locally advanced rectal cancer (LARC) patients with positive versus negative lateral pelvic lym...

    Authors: Shuai Li, Maxiaowei Song, Jian Tie, Xianggao Zhu, Yangzi Zhang, Hongzhi Wang, Jianhao Geng, Zhiyan Liu, Xin Sui, Huajing Teng, Yong Cai, Yongheng Li and Weihu Wang
    Citation: Radiation Oncology 2024 19:132

Annual Journal Metrics

  • Citation Impact 
    Journal Impact Factor: 3.3 (2023)    
    5-year Journal Impact Factor: 3.6 (2023)    
    Source Normalized Impact per Paper (SNIP): 1.203 (2024)    
    SCImago Journal Rank (SJR): 1.112 (2024)

    Speed 
    Submission to first editorial decision (median days): 16
    Submission to acceptance (median days): 135

    Usage 2024
    Downloads: 2,096,424
    Altmetric mentions: 233